Patients in the immune-tolerant phase of chronic HBV infection should be actively treated with antiviral therapy

Yuan HUANG

doi:10.3969/j.issn.1001-5256.2021.05.008

Volume 37 Issue 5

May 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(5): 1026-1026

PDF( 1825 KB)

Patients in the immune-tolerant phase of chronic HBV infection should be actively treated with antiviral therapy

DOI: 10.3969/j.issn.1001-5256.2021.05.008

Yuan HUANG

Department of Hepatology, Beijing Tsinghua Chang Gung Hospital, Tsinghua University, Beijing 102218, China

Received Date: 2021-03-12
Accepted Date: 2021-03-25
Published Date: 2021-05-20

Abstract

- Hepatitis B Virus,
- Hepatitis B, Chronic,
- Immune Tolerance,
- Therapeutics

FullText(HTML)

References(6)

References

[1]	LIU J, WANG J, YAN T, et al. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice[J]. J Viral Hepat, 2019, 26(10): 1170-1177. DOI: 10.1111/jvh.13156.
[2]	PAN X, CHEN J, ZHOU L, et al. Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus[J]. Sci Rep, 2020, 10(1): 13631. DOI: 10.1038/s41598-020-70644-4.
[3]	Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007. 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
[4]	KENNEDY P, SANDALOVA E, JO J, et al. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B[J]. Gastroenterology, 2012, 143(3): 637-645. DOI: 10.1053/j.gastro.2012.06.009.
[5]	SETO WK, LO YR, PAWLOTSKY JM, et al. Chronic hepatitis B virus infection[J]. Lancet, 2018, 392(10161): 2313-2324. DOI: 10.1016/S0140-6736(18)31865-8.
[6]	HE LY, WANG YL, TIAN X, et al. The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy: A retrospective study[J]. Medicine (Baltimore), 2020, 99(14): e19647. DOI: 10.1097/MD.0000000000019647.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (297) PDF downloads(70)

Patients in the immune-tolerant phase of chronic HBV infection should be actively treated with antiviral therapy

DOI: 10.3969/j.issn.1001-5256.2021.05.008

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Patients in the immune-tolerant phase of chronic HBV infection should be actively treated with antiviral therapy

DOI: 10.3969/j.issn.1001-5256.2021.05.008

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content